MedTrace Logo

Efficacy and Safety of Platelet-rich Plasma, Metformin and Cryotherapy in Treatment of Non-genital Warts

NCT06691542 · Status: NOT_YET_RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2024-11-15

No results posted yet for this study

Summary

1. Evaluation of the efficacy and safety of intralesional injection of autologous platelet-rich plasma in treatment of various types of cutaneous non genital warts
2. Evaluation of the efficacy and safety of intralesional injection of metformin in treatment of various types of cutaneous non genital warts
3. Comparing the efficacy and safety of intralesional injection of autologous platelet-rich plasma and intralesional injection of metformin with that of cryocautery in treatment of various types of cutaneous non genital warts.

Conditions

  • Non-Genital Warts

Interventions

DRUG

platelet-rich plasma

platelet-rich plasma, metformin and cryotherapy in treatment of non-genital warts

DRUG

Metformin

platelet-rich plasma, metformin and cryotherapy in treatment of non-genital warts

OTHER

cryotherapy

platelet-rich plasma, metformin and cryotherapy in treatment of non-genital warts

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Eman Mohamed Kamal Elsayed Youssef, prof · Professor of Dermatology and Venereology Faculty of Medicine, Assiut University

  • Alaa Mohamed Mahmoud Hamdy Ghazally, Lecturer · Lecturer of Dermatology and Venereology Faculty of Medicine, Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-14
Primary Completion
2025-03-31
Completion
2025-04-30

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06691542 on ClinicalTrials.gov